Apellis Pharmaceuticals, Inc. (APLS) Social Stream



Apellis Pharmaceuticals, Inc. (APLS): $39.92

0.15 (-0.37%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

APELLIS PHARMACEUTICALS INC (APLS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering APELLIS PHARMACEUTICALS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 12 $116 $28 $68.307 $66.09 3.35%
2021-11-12 12 $116 $28 $67.23 $66.09 1.72%
2021-11-17 11 $116 $28 $67.692 $66.09 2.42%
2021-11-24 12 $116 $28 $68.076 $66.09 3%
2021-11-29 12 $116 $28 $67.615 $66.09 2.31%
2021-12-15 13 $116 $28 $68.785 $66.09 4.08%
2022-01-05 13 $116 $28 $69 $66.09 4.4%
2022-01-11 13 $112 $28 $69.142 $66.09 4.62%
2022-01-26 13 $112 $34 $69.571 $66.09 5.27%
2022-03-02 13 $114 $34 $69.714 $66.09 5.48%
2022-03-16 13 $114 $34 $69.5 $66.09 5.16%
2022-03-17 13 $114 $34 $70.428 $66.09 6.56%
2022-03-22 13 $114 $34 $70.071 $66.09 6.02%
2022-04-04 12 $114 $34 $70.23 $66.09 6.26%
2022-04-14 12 $114 $34 $70.23 $66.09 6.26%
2022-04-19 12 $114 $34 $70.076 $66.09 6.03%
2022-04-21 12 $114 $34 $70.307 $66.09 6.38%
2022-04-28 12 $114 $39 $70.692 $66.09 6.96%
2022-05-10 12 $102 $40 $69.923 $66.09 5.8%
2022-05-12 12 $102 $40 $70.23 $66.09 6.26%
2022-06-01 13 $102 $40 $70.384 $66.09 6.5%
2022-06-17 13 $102 $40 $69.642 $66.09 5.37%
2022-07-25 13 $102 $40 $72.266 $66.09 9.34%
2022-08-09 13 $113 $40 $74.2 $66.09 12.27%
2022-08-13 13 $113 $40 $74.333 $66.09 12.47%
2022-08-24 13 $113 $40 $75.733 $66.09 14.59%
2022-09-06 13 $113 $40 $76.4 $66.09 15.6%
2022-10-04 13 $113 $40 $78.769 $66.09 19.18%
2022-10-17 13 $113 $40 $78.153 $66.09 18.25%
2022-10-21 13 $123 $40 $78.923 $66.09 19.42%
2022-11-04 13 $123 $40 $78.692 $66.09 19.07%
2022-11-08 13 $123 $40 $76.923 $66.09 16.39%
2022-11-10 13 $123 $40 $74.615 $66.09 12.9%
2022-11-18 13 $123 $40 $73.666 $66.09 11.46%
2023-01-03 13 $123 $40 $72.461 $66.09 9.64%
2023-01-26 12 $123 $40 $75.166 $66.09 13.73%
2023-02-16 12 $123 $40 $74.916 $66.09 13.35%
2023-02-21 14 $123 $47 $77.769 $66.09 17.67%
2023-02-22 14 $123 $51 $84.142 $66.09 27.31%
2023-02-23 14 $139 $51 $85.785 $66.09 29.8%
2023-02-24 14 $139 $51 $85.5 $66.09 29.37%
2023-03-09 14 $139 $51 $85.285 $66.09 29.04%
2023-03-13 14 $139 $51 $85.428 $66.09 29.26%
2023-04-17 14 $139 $58 $86.571 $66.09 30.99%
2023-04-24 14 $141 $58 $89.357 $66.09 35.21%
2023-05-02 14 $141 $58 $90.357 $66.09 36.72%
2023-05-05 14 $141 $58 $91.285 $66.09 38.12%
2023-05-08 14 $156 $58 $96.785 $66.09 46.44%
2023-05-09 14 $156 $76 $104.142 $66.09 57.58%
2023-06-06 14 $156 $76 $105 $66.09 58.87%
2023-07-17 14 $156 $76 $105.785 $66.09 60.06%
2023-07-21 14 $156 $40 $99.571 $66.09 50.66%
2023-07-31 14 $156 $40 $95.714 $66.09 44.82%
2023-08-01 14 $141 $32 $85.071 $66.09 28.72%
2023-08-02 14 $141 $32 $77.928 $66.09 17.91%
2023-08-03 14 $141 $32 $73.857 $66.09 11.75%
2023-08-07 14 $141 $29 $73.642 $66.09 11.43%
2023-08-29 14 $141 $29 $73 $66.09 10.46%
2023-09-08 13 $95 $29 $66.857 $66.09 1.16%
2023-09-15 13 $95 $29 $67.642 $66.09 2.35%
2023-10-06 13 $95 $38 $71.571 $66.09 8.29%
2023-10-12 13 $95 $38 $71.714 $66.09 8.51%
2023-10-27 13 $95 $44 $72.142 $66.09 9.16%
2023-10-31 13 $95 $44 $69.857 $66.09 5.7%
2023-11-03 14 $95 $42 $68.866 $66.09 4.2%
2023-11-06 14 $95 $42 $69.933 $66.09 5.81%
2023-11-09 15 $95 $42 $70.187 $66.09 6.2%
2023-11-29 15 $95 $44 $70.625 $66.09 6.86%
2023-12-01 15 $95 $44 $71.125 $66.09 7.62%
2023-12-04 15 $95 $44 $73.187 $66.09 10.74%
2023-12-15 15 $95 $39 $67.625 $66.09 2.32%
2023-12-18 15 $95 $39 $66.687 $66.09 0.9%

The Trend in the Analyst Price Target


Over the past 32 weeks, APLS's average price target has gone down $30.1.

APLS reports an average of 60.97% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-24 14 141 58 90.357 88.77 1.79%
2023-05-02 14 141 58 90.357 83.14 8.68%
2023-06-06 14 156 76 105.000 91.22 15.11%
2023-08-29 13 95 29 66.642 40.65 63.94%
2023-11-13 15 95 44 70.625 45.74 54.41%

APLS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.6 10 1 4 0 0 15

The Trend in the Broker Recommendations


Over the past 17 months, APLS's average broker recommendation rating worsened by 0.14.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, APELLIS PHARMACEUTICALS INC's variance in analysts' estimates is lower than -7625.6% of them.
  • In the context of Pharmaceutical Products stocks, APELLIS PHARMACEUTICALS INC's number of analysts covering the stock is greater than 7233% of them.
  • In the context of Pharmaceutical Products stocks, APELLIS PHARMACEUTICALS INC's average analyst price target is higher than 7058.67% of them.
  • In the context of Pharmaceutical Products stocks, APELLIS PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 1836.68% of them.

Stocks similar to APELLIS PHARMACEUTICALS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ZLAB, RDY, and BGNE.

Is APLS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!